Dark Matter Blog

Archive for April, 2019

Arrakis achieves escape velocity

April 18th, 2019
by Michael Gilman, PhD
CEO, Arrakis

When last we spoke (here and here), Arrakis had just achieved liftoff with a $38M Series A financing in February 2017, and we were awash in fascinating and, in some cases, vexing questions. Two of my own questions that stand out upon rereading those posts from two years ago are: Is medicinal chemistry truly limited […]

Back to Top